Voyager Therapeutics (VYGR) FCF Margin Growth (3y) (2018 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) FCF Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | -63,107.00 |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 4.25 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 12,129.00 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 190,033.00 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -1.35 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 86,497.00 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 10,262.00 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 371.00 |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - | -77,208.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -77,208.00 |
| Mar 31, 2026 | -136,766.00 |
| Dec 31, 2025 | -105,154.00 |
| Sep 30, 2025 | -19,313.00 |
| Jun 30, 2025 | 208,308.00 |
| Mar 31, 2025 | -579,039.00 |
| Dec 31, 2024 | -27,254.00 |
| Sep 30, 2024 | 132,730.00 |
| Jun 30, 2024 | 158,083.00 |
| Mar 31, 2024 | 62,347.00 |
| Dec 31, 2023 | 36,337.00 |
| Sep 30, 2023 | -44,782.00 |
| Jun 30, 2023 | 3,875.00 |
| Mar 31, 2023 | 24,951.00 |
| Dec 31, 2022 | 93,196.00 |
| Sep 30, 2022 | 7,123.00 |
| Jun 30, 2022 | -267,101.00 |
| Mar 31, 2022 | 281,016.00 |
| Dec 31, 2021 | 127,724.00 |
| Sep 30, 2021 | -55,862.00 |